Tech Company Financing Transactions
Curie Therapeutics Funding Round
Curie Therapeutics, based in Cambridge, received $75 million from Access Industries, Atlas Venture and RA Capital.
Transaction Overview
Company Name
Announced On
12/2/2021
Transaction Type
Venture Equity
Amount
$75,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Cambridge, MA 02114
USA
Cambridge, MA 02114
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Curie Therapeutics is a fully integrated next generation radiopharmaceutical company that brings together experts in ligand discovery, radiochemistry, radiobiology and oncology translational and clinical research in order to build a pipeline across a range of solid tumor types.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Simon Read
Chief Scientific Officer
Alonso Ricardo
VP - Bus. Development
Sandy Mong
Browse more venture capital transactions:
Prev: 12/2/2021: Quince venture capital transaction
Next: 12/2/2021: StormSensor venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on all VC transactions involving tech companies. All VC database entries reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs